GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets
Feb 06, 2026 17:45 HKT |  |
|
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share
Feb 06, 2026 17:01 HKT | |
|
歌禮製藥-B（01672）獲新加坡政府投資公司首次入股 涉資約1億美元
Feb 06, 2026 16:56 HKT | |
|
歌礼制药-B（01672）获新加坡政府投资公司首次入股 涉资约1亿美元
Feb 06, 2026 16:50 HKT | |
|
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis
Feb 06, 2026 14:17 HKT |  |
|
雲頂新耀維適平(R)獲中國國家藥品監督管理局批准上市 為中重度潰瘍性結腸炎治療提供新選擇
Feb 06, 2026 14:11 HKT | |
|
云顶新耀维适平(R)获中国国家药品监督管理局批准上市 为中重度溃疡性结肠炎治疗提供新选择
Feb 06, 2026 14:03 HKT | |
|
Distinct Healthcare Successfully Listed on HKEX, Bolstered by Premium Customer Base and All-Star Cornerstone Investors
Feb 06, 2026 11:44 HKT | |
|
歌礼制药-B（01672）获新加坡政府投资公司入股6412.8万股 涉资约1亿美元
Feb 05, 2026 20:14 HKT | |
|
歌禮製藥-B（01672）獲新加坡政府投資公司入股6412.8萬股 涉資約1億美元
Feb 05, 2026 20:14 HKT | |
|
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share
Feb 05, 2026 20:14 HKT | |
|
卓正医疗上市在即：认购火爆 以独特商业模式撬动业绩逆势增长
Feb 05, 2026 14:24 HKT | |
|
卓正醫療上市在即：認購火爆 以獨特商業模式撬動業績逆勢增長
Feb 05, 2026 14:24 HKT | |
|
云顶新耀宣布与麦科奥特达成MT1013独家商业化许可协议
Feb 05, 2026 10:55 HKT | |
|
雲頂新耀宣佈與麥科奧特達成MT1013獨家商業化許可協議
Feb 05, 2026 10:55 HKT | |
|
TANAKA PRECIOUS METAL TECHNOLOGIES在体外诊断试剂等的各种检测试剂盒的受托制造中 确立全面解决方案体制
Feb 05, 2026 10:00 HKT |  |
|
TANAKA PRECIOUS METAL TECHNOLOGIES在接受委託製造體外診斷試劑等各種檢驗套組中 確立綜合式的解決方案體制
Feb 05, 2026 10:00 HKT | |
|
TANAKA PRECIOUS METAL TECHNOLOGIES, 체외 진단약 등 각종 검사 키트 위탁 제조를 위한 토탈 솔루션 체계 구축
Feb 05, 2026 10:00 HKT | |
|
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States
Feb 05, 2026 05:00 HKT |  |
|
爱克发医疗荣膺2026年KLAS(R)美国三大企业影像领域最佳供应商
Feb 05, 2026 05:00 HKT | |
|